The Senhance System is already approved for pediatric patients in the EU and Japan.
Celsion Corporation Announces Company Name Change to Imunon, To Trade Under Symbol ‘IMNN’ Effective As Of Sept. 21
Celsion Corporation (NASDAQ:CLSN), a clinical-stage drug development company, today announced a company name change to Imunon, Inc., reflecting the evolution of the Company's business focus and its
